Healthcare provider profile · identity verified

Mark Joseph Hare, MD

Family Practice · OMAHA, NE · NPI 1790006914

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	388	92
Levothyroxine Sodium	Levothyroxine Sodium	278	52
Amlodipine Besylate	Amlodipine Besylate	204	47
Lisinopril	Lisinopril	196	51
Losartan Potassium	Losartan Potassium	188	39
Hydrochlorothiazide	Hydrochlorothiazide	177	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	161	30
Meloxicam	Meloxicam	161	40
Omeprazole	Omeprazole	153	38
Simvastatin	Simvastatin	129	27
Pantoprazole Sodium	Pantoprazole Sodium	126	29
Duloxetine Hcl	Duloxetine Hcl	123	27
Albuterol Sulfate Hfa	Albuterol Sulfate	121	36
Trazodone Hcl	Trazodone Hcl	118	20
Alprazolam	Alprazolam	117	17
Tamsulosin Hcl	Tamsulosin Hcl	113	34
Gabapentin	Gabapentin	111	28
Naproxen	Naproxen	100	22
Metformin Hcl	Metformin Hcl	96	24
Metoprolol Succinate	Metoprolol Succinate	95	22
Furosemide	Furosemide	94	27
Metformin Hcl Er	Metformin Hcl	92	21
Rosuvastatin Calcium	Rosuvastatin Calcium	87	19
Pravastatin Sodium	Pravastatin Sodium	85	17
Carvedilol	Carvedilol	82	14
Escitalopram Oxalate	Escitalopram Oxalate	78	19
Eliquis	Apixaban	72	13
Pioglitazone Hcl	Pioglitazone Hcl	71	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	66	suppressed
Pregabalin	Pregabalin	63	19
Tramadol Hcl	Tramadol Hcl	62	14
Sertraline Hcl	Sertraline Hcl	51	suppressed
Clopidogrel	Clopidogrel Bisulfate	50	suppressed
Glimepiride	Glimepiride	46	suppressed
Lorazepam	Lorazepam	46	suppressed
Ozempic	Semaglutide	46	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	45	11
Quetiapine Fumarate	Quetiapine Fumarate	45	suppressed
Allopurinol	Allopurinol	43	11
Finasteride	Finasteride	42	14
Oxybutynin Chloride Er	Oxybutynin Chloride	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	39	16
Potassium Chloride	Potassium Chloride	39	13
Torsemide	Torsemide	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	suppressed
Bupropion Xl	Bupropion Hcl	35	suppressed
Clonazepam	Clonazepam	35	suppressed
Montelukast Sodium	Montelukast Sodium	35	suppressed
Aripiprazole	Aripiprazole	34	suppressed
Atenolol	Atenolol	34	suppressed
Chlorthalidone	Chlorthalidone	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	15
Januvia	Sitagliptin Phosphate	34	11
Warfarin Sodium	Warfarin Sodium	34	suppressed
Myrbetriq	Mirabegron	33	suppressed
Celecoxib	Celecoxib	30	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Ibuprofen	Ibuprofen	28	12
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Estradiol	Estradiol	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	25	suppressed
Valsartan	Valsartan	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	19
Mounjaro	Tirzepatide	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Topiramate	Topiramate	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Trintellix	Vortioxetine Hydrobromide	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Fluconazole	Fluconazole	18	11
Methylprednisolone	Methylprednisolone	18	13
Spironolactone	Spironolactone	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Diazepam	Diazepam	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Glipizide	Glipizide	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	16	suppressed
Nabumetone	Nabumetone	16	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Levetiracetam Er	Levetiracetam	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Restasis	Cyclosporine	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Fyavolv	Norethindrone Ac/Eth Estradiol	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Temazepam	Temazepam	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Mesalamine Er	Mesalamine	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Verapamil Er Pm	Verapamil Hcl	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error